CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Lotrel® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00234871
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:55.075107+00:00
Published At: 2008-07-15T00:00:00+00:00
Record Updated At: 2008-07-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hypertension", "Diabetes", "Proteinuria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2008-07-15"
protocolSection.identificationModule.nctId: "NCT00234871"
protocolSection.identificationModule.officialTitle: "A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka\u00ae and Lotrel\u00ae on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.